National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 528644

Case Details

VAERS ID: 528644 (history)  
Form: Version 1.0  
Age: 11.0  
Gender: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-04-16
Entered: 2014-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Allodynia, Blood test normal, CSF cell count normal, Electromyogram normal, Erythema, Fatigue, Insomnia, Nuclear magnetic resonance imaging normal, Pain, Pain in extremity, Skin warm, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Neurological tests (unknown date): Generalised allodynia; Unspecified blood tests (unknown date): No infection, inflammation neither autoimmune diseases; Cerebrospinal fluid test (unknown date): Normal; Head and neck magnetic resonance imaging (unknown date): Normal; Electromyography unknown date: Normal; Blood test, No infection, inflammation neither autoimmune dise not provided; Neurological magnetic resonance imaging, Normal
CDC Split Type: WAES1404MEX009272

Write-up: This spontaneous report as received from a physician refers to a 11 year old female patient. Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with GARDASIL dose 1, 0.5 ml dose (lot, and route not reported), but she did not receive the complete vaccination schedule. So, 11 months later of receiving the first GARDASIL dose the patient''s treating physcian prescribed her to re-start a new vaccination schedule. On an unknown date, after receiving the second dose of the new schedule of GARDASIL 0.5 ml (lot and route not reported), the patient experienced intense arm pain where was administered which lasted a week. On an unknown date, after receiving the third dose of GARDASIL 0.5 ml dose (lot and route not reported), the patient experienced intense arm pain again where the vaccine was administered accompanied by swollen, redness and hot hand. Two weeks later this symptoms were extended to another arm and finally to the whole body. The pain was accompanied by severe Paresthesia. So, the patient was disabled because of her symptoms, so she stopped going to school. In addition the patient developed insomnia and deep fatigue. The reporter denied any trauma history, neither personal nor familiar psychiatric problem in the patient. On an unknown date, the patient underwent to several diagnostic tests including: Unspecified blood tests that were negative for infection, inflammation and autoimmune diseases, cerebrospinal fluid test which showed normal result, head and neck magnetic resonance imaging and electromyography revealed normal results. Seven months later of the beginning of the patient symptoms she continues experiencing generalised pain, paresthesia, insomnia and fatigue. The patient received therapy with unspecified analgesic, anti-inflammatories and anti-neuropathies but they were ineffective. On an unknown date, seven months later of the beginning of the symptoms, a physical evaluation was performed and showed a girl with obvious data of suffering caused by her pain and paresthesia. In addition a neurological test was performed that showed generalised allodynia. The 18 tender points were positive for fibromyalgia; there are not any data of articular phlogosis. According to the reporter the probable diagnostic is complex regional pain syndrome (reflex sympathetic dystrophy) that evolved to fibromyalgia after the vaccination with GARDASIL. The outcome of severe paresthesia, deep fatigue, insomnia, fibromyalgia, generalized allodynia and generalized pain was reported as not recovered. The outcome of swollen, redness and hot hard, did not received the complete vaccination schedule and swollen/hot extended to the whole body was unknown. The events of paresthesia and generalized pain were considered serious due to disability by the reporter. This is one of two reports from the same source (2014PVMX0122). Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=528644


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166